Nasdaq-listed Sonnet BioTherapeutics has announced a definitive agreement to merge with Rorschach I LLC, forming Hyperliquid Strategies Inc. (HSI). The new entity, according to a Monday press release, will debut as a crypto asset management powerhouse, while boasting a treasury of 12.6 million HYPE tokens and over $305 million in cash, valued at an estimated … Continue reading Sonnet, Rorschach Strike $888M Deal To Launch Hyperliquid (HYPE) Treasury